Skip to main content
ALIVUS LIFE SCIENCES LIMITED logo

ALIVUS LIFE SCIENCES LIMITED — Investor Relations & Filings

Ticker · ALIVUS ISIN · INE03Q201024 LEI · 335800RYVA1DKP696G32 BSE.NS Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2024-05-31 Regulatory Filings
Country IN India
Listing BSE.NS ALIVUS

About ALIVUS LIFE SCIENCES LIMITED

https://www.alivus.com

Alivus Life Sciences Limited is a pharmaceutical organization dedicated to the formulation, production, and commercialization of a broad spectrum of healthcare solutions. The company operates across multiple therapeutic categories, including gastroenterology, anti-infectives, pain management, and nutritional supplements. Its product range includes diverse delivery formats such as tablets, capsules, syrups, and injectable medications. Alivus Life Sciences focuses on maintaining rigorous quality control protocols and manufacturing excellence to deliver reliable therapeutic outcomes. The company utilizes a robust distribution infrastructure to supply its pharmaceutical products to healthcare providers and patients, prioritizing the accessibility of essential medicines and the continuous expansion of its therapeutic portfolio.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2209 characters) addressed to stock exchanges regarding the schedule of an Analyst / Institutional Investors' Conference. It references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an announcement of an upcoming investor conference, not a financial report or detailed presentation. It does not contain financial data, management discussion, or detailed report content. Given the short length and nature of the document as an announcement of an event, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-05-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2211 characters) addressed to stock exchanges regarding the schedule of an Analyst / Institutional Investors' Conference. It references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an announcement of an upcoming investor conference, not a financial report or detailed presentation. It does not contain financial data, management discussion, or detailed report content. Given the short length and nature of the document as an announcement of an event, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2091 characters) addressed to stock exchanges (BSE and NSE) regarding an upcoming investor/analyst meeting scheduled for May 22, 2024. It references compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) – Regulations, 2015, which pertains to disclosure of material events or information. The content is an intimation about a meeting rather than a detailed report or presentation. It does not contain financial data, management discussion, or detailed report content. Given the short length and nature of the document as an announcement of an investor/analyst meeting, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-05-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges (BSE and NSE) disclosing an upcoming investor/analyst meeting as per SEBI regulations. It references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) – Regulations, 2015, which pertains to disclosure of material events. The content is an intimation about the schedule and mode of investor/analyst meetings, not a financial report or detailed presentation. The document length is only 2134 characters, indicating it is a brief announcement rather than a full report. There is no financial data, no detailed presentation, no voting results, no management changes, or other report content. This fits the category of a Regulatory Filing (RNS), which is a general regulatory announcement and a fallback category for miscellaneous filings that do not fit other specific categories.
2024-05-14 English
Monitoring Agency Report
Regulatory Filings
2024-05-14 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter dated May 4, 2024, addressed to the National Stock Exchange of India Ltd. and BSE Ltd., referencing a scrip code and scrip name. It mentions compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and encloses copies of newspaper advertisements informing about a Postal Ballot Notice and e-Voting information. The letter requests the information to be taken on record and states that the advertisement has been published in newspapers and made available on the company's website. There is no substantive financial data, management discussion, or detailed report content. The document is essentially an announcement of the publication of a notice related to shareholder voting procedures, not the notice itself or any financial report. It is also not a certification or insider dealing report. Given the nature of the content as an announcement of a regulatory compliance advertisement, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-05-04 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.